Michael Gleeson, SVP, Corporate Accounts at GenMark Diagnostics, Inc. (GNMK), sold 35,500 shares at $17.01 ($604K) on 2021-02-26, disclosed to the SEC on 2021-03-01.
Seasonal sale ($604k) by SVP, Corporate Accounts — this insider has traded GNMK in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.01 | 17,750 | $302K | 50.0% |
| 2 | $17.01 | 17,750 | $302K | 50.0% |
| Total | $17.01 avg | 35,500 | $604K | 100% |
| Filing → |
| GNMK | SELL | 2021-01-25 | $939K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $43K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $23K | — | Filing → |